TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: improvement in disease measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence and severity of gastrointestinal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: median exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall LWHF score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MMP-8 levels in inflammatory infiltrate cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMP-9 levels in endothelial cells of blood vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Craniofacial variability index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBAC scores at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amenorrhea rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate defined by PBAC below 75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excessive polypharmacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-12 physical health composite score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SF-12 mental health composite score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive modulation of glucose-dependent insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean serum sodium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in air and bone thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCS/SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MHI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean FVII concentration increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: N2 sleep percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of postoperative hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma GHB exposure (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation and dizziness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of unscheduled medical visits for asthma
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sickness absence
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Blood lead level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 6-min walk distance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGRQ symptom score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of MEES
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: miss rate for all adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: miss rate for adenomas of ≤5 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in body surface EMF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean spinal scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEP3 score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IIEF EF domain score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: level of functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NRS-U evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SVS-U evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPI-U evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal weight management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Childhood obesity prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Psychological symptom distress
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Average post-meal blood glucose (BG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial hypoglycemia risk (LBGI)
Endpoint domain: Adverse events/effects
Primary endpoint: quality-of-life outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Slowing of inspection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Pulmonary Artery Pressure (PAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood d-dimer levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: decrease in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pressure Rate Quotient (PRQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average number of statin prescription fill days
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Likelihood to fill prescriptions for at least 120 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Iodine stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in parkinsonian signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of positive responses to head-up tilt testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BFM subscore change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of sore throat postoperatively
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of seizure after treatment
Endpoint domain: Adverse events/effects
Primary endpoint: plasma and whole blood viscosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: therapeutic effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of LAC and LBMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of first myocardial infarction (MI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: low density lipoprotein cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: plasma triglyceride concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global health status scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain interference with daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adequate fluid intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Employment for black males
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Earnings for black males
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Earnings for white males
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Employment for white females
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Earnings for white females
Endpoint domain: Life impact
Endpoint subdomain: Economic functioning
Primary endpoint: Ischemia-driven target-lesion revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Target-vessel revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: lung cancer mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: serum concentration of oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum concentration of neurotensin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: serum concentration of orexin A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 30-day point prevalence abstinence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRSA bacteraemia rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: C difficile infection rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Plasma levels of ADMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma levels of SDMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma levels of L-arginine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: composite of death, myocardial [re]infarction, or severe recurrent ischemia at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Prevention of PPE grade III
Endpoint domain: Adverse events/effects
Primary endpoint: change in percent stenosis of the most severe proximal lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: primary clinical endpoints (death from coronary causes, nonfatal myocardial infarction, stroke, or revascularization for worsening ischemia)
Endpoint domain: Mortality/survival
Primary endpoint: change in systolic wall thickening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: occupational functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Amplitude of the P3 component
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Physiological indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: engagement with audiologist
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Levels of peripheral antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of cord antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of first malaria episode in infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of vertebral fractures (VF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of spinal vertebral height (SVH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of wound infection
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h glucose fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postprandial glucose excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: glucagon excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: triglyceride excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development of factor VIII inhibitors
Endpoint domain: Adverse events/effects
Primary endpoint: 7-day recall ratings of pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean anterior knee pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swelling reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMSSD (high-frequency HRV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SUDEP-7 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC survival
Endpoint domain: Mortality/survival
Primary endpoint: anemia correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: renal clearance of lithium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Measures of cognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in nausea level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of antiemetic medications requested
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean lesion sizes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain on VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FIHOA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime systolic ambulatory blood pressure measurement (ABPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual analogue scale (VAS) assessment of problem with DOT-HTN
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of Venous Thromboembolism (VTE)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of home hemodialysis training sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Medical safety measured as complication frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Lag time from symptoms to intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Mean outpatient cost per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement in VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in BQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in median nerve sensory nerve action potential distal latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mortality rates at 6 months of age
Endpoint domain: Mortality/survival
Primary endpoint: mean pain score in the recovery room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for opioid administration
Endpoint domain: Adverse events/effects
Primary endpoint: hemodynamic changes during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Errors in anticoagulant prescription
Endpoint domain: Adverse events/effects
Primary endpoint: Hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Hyperglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: MDRO ventilator-associated pneumonia (VAP)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean pain experienced
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe pain-free status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean C(max) of serum LNG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean T(max) of serum LNG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve for serum LNG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfusional requirements of blood and plasma units
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Injection-associated pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median calculated charge for outpatient treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of episodes managed without hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Preference for outpatient care
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Infarct size as a fraction of left ventricular size (IS/LVmass)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of iatrogenically induced overdose or death
Endpoint domain: Mortality/survival
Primary endpoint: Effectiveness of oxycodone dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pap testing use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Response bias toward rewarded condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for morphine in the postanesthesia care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery 48 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HIV RNA levels at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal PlGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord blood sFlt‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cord blood PlGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased postablation tumor pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of further bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tissue Sensitivity (TS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average absolute power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exercise efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brachial artery blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: κ agreement between graders for TF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: κ agreement between graders for TI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of times the children's teeth were cleaned or brushed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of shared eating utensils
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BNP levels predicting the need for ICU care
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of low birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Histamine bronchoreactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IGA success (clear/almost clear)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heat pain intensity (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for pain intensity to decrease by 33%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: residual depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: insomnia
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: probability of survival free from stroke and device failure at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: functional capacity improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: EIE incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of CDC class C disease
Endpoint domain: Mortality/survival
Primary endpoint: Weight z-score at PMA 32 and 36 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-Specific Survival
Endpoint domain: Mortality/survival